The relationships between risk factors and the distribution of retinopathy lesions in type 2 diabetes

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 5, 2006, Pages 619-623

  Hove, Marianne Nørgård ^a   Kristensen, Jette Kolding ^b   Lauritzen, Torsten ^a   Bek, Toke ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Computer assisted grading; Retinopathy; Risk factors; Screening; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C;

ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; COMPUTER ANALYSIS; CONTROLLED STUDY; CORRELATION FUNCTION; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; EYE PHOTOGRAPHY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANEURYSM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA HEMORRHAGE; RETINA MACULA LUTEA; RISK FACTOR;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; RISK FACTORS;

EID: 33748273083     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2006.00710.x     Document Type: Article

References (25)

1. Aldington SJ, Kohner EM, Meuer S, Klein R & Sjolie AK (1995): Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study. Diabetologia 38: 437-444.
2. Bek T, Aldington SJ, Englmeier K-H, Hejlesen OK & McCanna L (2003): TOSCA Imaging. Final Report. [EU Project IST-1999-12364.]Aarhus: University of Aarhus 45-47.
3. Bek T & Helgesen A (2001): The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease. Acta Ophthalmol Scand 79: 501-505.
4. Bland JM & Altman DG (1986): Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
5. Chew EY, Klein ML, Ferris FL III, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ & Miller D (1996): Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol 114: 1079-1084.
6. Dobree JH (1970): Simple diabetic retinopathy. Evolution of the lesions and therapeutic considerations. Br J Ophthalmol 54: 1-10.
7. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group (1987): Treatment techniques and clinical guidelines for photocoagulation of diabetic macular oedema. ETDRS Report 2. Ophthalmology 94: 761-774.
8. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group (1991): Grading diabetic retinopathy from stereoscopic colour fundus photographs: An extension of the modified Airlie House classification. ETDRS Report 10. Ophthalmology 98: 786-806.
9. Henricsson M, Nilsson A, Groop L, Heijl A & Janzon L (1996): Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycaemic control. Acta Ophthalmol Scand 74: 523-527.
10. Hove MN, Kristensen JK, Lauritzen T & Bek T (2004b): Quantitative analysis of retinopathy in type 2 diabetes: Identification of prognostic parameters for developing visual loss secondary to diabetic maculopathy. Acta Ophthalmol Scand 82: 679-685.
11. Hove MN, Kristensen JK, Lauritzen T & Bek T (2004a): The prevalence of retinopathy in an unselected population of type 2 diabetes patients from Århus County, Denmark. Acta Ophthalmol Scand 82: 443-448.
12. Klein R, Klein BE, Moss SE & Cruickshanks KJ (1994): Relationship of hyperglycaemia to the longterm incidence and progression of diabetic retinopathy. Arch Intern Med 154: 2169-2178.
13. Klein R, Klein BE, Moss SE, Davis MD & DeMets DL (1984): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102: 527-532.
14. Klein R, Meuer SM, Moss SE & Klein BE (1995): Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol 113: 1386-1391.
15. Klein R, Moss SE, Klein BE, Davis MD & DeMets DL (1989): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular oedema. Ophthalmology 96: 1501-1510.
16. Klein BE, Moss SE, Klein R & Surawicz TS (1991): The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 98: 1261-1265.
17. Larsen N, Godt J, Grunkin M, Lund-Andersen H & Larsen M (2003a): Automated detection of diabetic retinopathy in a fundus photographic screening population. Invest Ophthalmol Vis Sci 44: 767-771.
18. Larsen M, Godt J, Larsen N et al. (2003b): Automated detection of fundus photographic red lesions in diabetic retinopathy. Invest Ophthalmol Vis Sci 44: 761-766.
19. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD & Polak BC (2002): Blood pressure, lipids, and obesity are associated with retinopathy: The Hoorn Study. Diabetes Care 25: 1320-1325.
20. Matthews DR, Stratton IM, Aldington SJ, Holman RR & Kohner EM (2004): Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus. UK Prospective Diabetes Study 69. Arch Ophthalmol 122: 1631-1640.
21. Stratton IM, Adler AI, Neil HA et al. (2000): Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321: 405-412.
22. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE &R Matthews DR (2001): UKPDS 50: risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia 44: 156-163.
23. UK Prospective Diabetes Study (UKPDS) Group (1998b): Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853.
24. UK Prospective Diabetes Study Group (1998a): Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317: 703-713.
25. Wilkinson CP, Ferris FL III, Klein RE et al. (2003): Proposed international clinical diabetic retinopathy and diabetic macular oedema disease severity scales. Ophthalmology 110: 1677-1682.